Bergen New Bridge Medical Center joined Guardian Research Network Inc., a Spartanburg, S.C.-based health care system research network focused on translating data into cures for better overall patient health and outcomes, according to a May 10 announcement.
The alliance with Bergen New Bridge, which is the fourth largest publicly owned hospital in the country, will enable GRN to extend beyond its current focus on cancer research and into diabetes, rare diseases, mental health and other illnesses.
“We can help identify cancers and other diseases earlier to eventually improve treatment outcomes,” said Bergen New Bridge President and CEO Deborah Visconi. “This aligns with our mission to bring true population health and access to health care at critical early stages to underrepresented populations across the county.”
Representing millions of patients across the country, GRN focuses on advancing health care data technology, clinical research trials, and real-world data science.
GRN works with health systems and life science companies across the country to increase participation in data-driven clinical trials, optimize therapeutic and diagnostic studies, and employ data to improve patient access in underserved communities.
“We are thrilled to partner with Bergen New Bridge Medical Center,” says GRN Chief Executive Officer and Chairman Bruce Holstien. “Bergen’s excellent reputation, expert medical services, and clinical innovations overlayed by their mission to serve all, are a perfect match for the Guardian Research Network. Our collective efforts to democratize clinical trials, accelerate cures for disease, and develop the core medical data research engine for the coming decade are further enhanced by Bergen’s entry into our now 25+ state-represented network of health systems.”